A Trial of HRS-7085 Tablet in Healthy Participants With and Without Food Effect.

Inclusion criteria

• Ability to understand the trial procedures and possible adverse events, volunteers to participate in the trial.
• Male or female aged between 18 years and 55 years (inclusive) at the date of signed consent form.
• Total body weight 45 kg~100 kg (inclusive) at screening, and body mass index (BMI) between 18 and 32 kg/m2 (inclusive).
• For healthy subjects, no clinically significant abnormalities.
• Men and women of childbearing potential (WOCBP) must agree to take effective contraceptive methods

Exclusion criteria

• Known medical history of severe disease in cardiovascular, liver, kidney, digestive tract, mental nerve, hematology, metabolic disorders, etc.
• Severe injuries or major surgeries within 3 months before dosing.
• Subjects with infectious disease.
• Live/attenuated vaccine within 3 months prior to dosing or any vaccine during the trial.
• Blood donation or loss of ≥ 200 mL of blood within 1 month prior to dosing, or ≥ 400 mL of blood within 3 months prior to dosing; or receive a blood transfusion within 2 months prior to dosing.
• Clinically significant abnormalities in 12-Lead ECG
• More than 5 cigarettes daily (or products with equivalent amount of nicotine) for 3 months prior to screening, or positive cotinine test at screening or baseline.
• Positive urine drug at screening or baseline.
• Subject who cannot perform venous blood sampling.
• Known history or suspected of being allergic to the study drugs and their excipients.
• Use of prescription medicine within 2 weeks, or OTC medicine, within 1-week or 5 half-lives prior to dosing.
• History of alcohol abuse within 3 months prior to screening, or positive alcohol breath test at screening or baseline.
• Participation in clinical trials of other investigational drugs or medical devices within 1 month or 5 half-lives prior to dosing.
• Special dietary requirements that cannot follow the meal plan in the food effect study.
• In the investigator's judgment, may increase the risk to the subject.
• Unwilling or unable to comply with the Lifestyle Guidelines detailed in this protocol.